Table 2 Outcomes in the two study arms
Outcomes | Early ART arm | Deferred ART arm | p value |
|---|---|---|---|
All-cause mortality | 11.8% (20/169) | 13.4% (26/194) | 0.860a |
Number of patients in the deceased population who did not initiate ART | 55.0% (11/20) | 88.5% (23/26) | 0.026 |
AIDS-defining events | 10.1% (17/169) | 13.4% (26/194) | 0.412 |
Patients admitted to ICU | 1.8% (3/169) | 1.5% (3/194) | 1.000 |
Requirement for intubation | 1.2% (2/169) | 0.5% (1/194) | 0.904 |
IRIS | 1.2% (2/169) | 1.5% (3/194) | 1.000 |
Adverse events | 41.4% (70/169) | 37.1% (72/194) | 0.465 |
Adverse events grade 3 or 4 | 16.6% (28/169) | 17.5% (34/194) | 0.919 |
Virological suppression at week 24 | 67.4% (58/86) | 56.5% (61/108) | 0.159 |
Virological suppression at week 48 | 81.2% (82/101) | 81.5% (88/108) | 1.000 |